相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma
Katharina Seystahl et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma
Li Peng et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Current Therapeutic Strategies for Glioblastoma
Julien Rossignol et al.
BRAIN SCIENCES (2020)
Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells
Alessandra Affinito et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
Zhaoying Fu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Nucleic acid -based drug delivery strategies
Xuyu Tan et al.
JOURNAL OF CONTROLLED RELEASE (2020)
An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma
Sorah Yoon et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
A Meta-Analysis of Survival Outcomes Following Reoperation in Recurrent Glioblastoma: Time to Consider the Timing of Reoperation
Yu-Hang Zhao et al.
FRONTIERS IN NEUROLOGY (2019)
RNA Aptamers Targeting Integrin α5β1 as Probes for Cyto- and Histofluorescence in Glioblastoma
Pierre Fechter et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel nanoconjugates that can pass the blood brain barrier
Sirong Shi et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Efficient Epidermal Growth Factor Receptor Targeting Oligonucleotide as a Potential Molecule for Targeted Cancer Therapy
Tao Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis
Noemi Bellassai et al.
FRONTIERS IN CHEMISTRY (2019)
Enhanced Efficacy of Temozolomide Loaded by a Tetrahedral Framework DNA Nanoparticle in the Therapy for Glioblastoma
Wei Fu et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
Jun Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells
Alessandra Affinito et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
DNA aptamers from whole-cell SELEX as new diagnostic agents against glioblastoma multiforme cells
Qiaoyi Wu et al.
ANALYST (2018)
Classification of cancer cells using computational analysis of dynamic morphology
Mohammad R. Hasan et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2018)
Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer
Abdullah Tahir Bayrac et al.
JOURNAL OF BIOSCIENCES (2018)
Current Challenges and Opportunities in Treating Glioblastoma
Andrea Shergalis et al.
PHARMACOLOGICAL REVIEWS (2018)
Aptamers in the Therapeutics and Diagnostics Pipelines
Harleen Kaur et al.
THERANOSTICS (2018)
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
Carla Lucia Esposito et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells
Xingmei Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Conventional and advanced magnetic resonance imaging in patients with high-grade glioma
Whitney B. Pope et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
A Critical Overview of Targeted Therapies for Glioblastoma
Kewal K. Jain
FRONTIERS IN ONCOLOGY (2018)
Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications
Emma M. Hays et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (L-γ-glutamylglutamine)-paclitaxel nanoconjugates
Zimiao Luo et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2017)
Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier
Ilaria Monaco et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells
Carla L. Esposito et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Aptamers as radiopharmaceuticals for nuclear imaging and therapy
Marlies Gijs et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
Identification of an Interfering Ligand Aptamer for EphB2/3 Receptors
Paola Amero et al.
NUCLEIC ACID THERAPEUTICS (2016)
Management of glioblastoma after recurrence: A changing paradigm
Supriya Mallick et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2016)
Glioblastoma: Overview of Disease and Treatment
Mary Elizabeth Davis
CLINICAL JOURNAL OF ONCOLOGY NURSING (2016)
Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells
Simona Camorani et al.
ONCOTARGET (2015)
Pitfalls in le neuroimaging of glioblastoma in le era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response
Raymond Y. Huang et al.
FRONTIERS IN NEUROLOGY (2015)
One-step tumor detection from dynamic morphology tracking on aptamer-grafted surfaces
Mohammed Arif I. Mahmood et al.
TECHNOLOGY (2015)
Eph receptors as therapeutic targets in glioblastoma
B. W. Day et al.
BRITISH JOURNAL OF CANCER (2014)
Synthesis of AS1411-Aptamer-Conjugated CdTe Quantum Dots with High Fluorescence Strength for Probe Labeling Tumor Cells
Mona Alibolandi et al.
JOURNAL OF FLUORESCENCE (2014)
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRβ Aptamer
Simona Camorani et al.
MOLECULAR THERAPY (2014)
Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients
Lin-Fang Wang et al.
ONCOLOGY REPORTS (2014)
Cell-SELEX Aptamer for Highly Specific Radionuclide Molecular Imaging of Glioblastoma In Vivo
Xidong Wu et al.
PLOS ONE (2014)
Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
Baby Santosh et al.
BIOMED RESEARCH INTERNATIONAL (2014)
A U87-EGFRvIII cell-specific aptamer mediates small interfering RNA delivery
Xingmei Zhang et al.
BIOMEDICAL REPORTS (2014)
DNA aptamers that target human glioblastoma multiforme cells overexpressing epidermal growth factor receptor variant III in vitro
Yan Tan et al.
ACTA PHARMACOLOGICA SINICA (2013)
Proliferation and migration of tumor cells in tapered channels
Yuan Wan et al.
BIOMEDICAL MICRODEVICES (2013)
Aptamer Identification of Brain Tumor-Initiating Cells
Youngmi Kim et al.
CANCER RESEARCH (2013)
Molecular recognition force spectroscopy study of the dynamic interaction between aptamer GBI-10 and extracellular matrix protein tenascin-C on human glioblastoma cell
Yongjun Li et al.
JOURNAL OF MOLECULAR RECOGNITION (2013)
Aptamer-modified magnetic nanoprobe for molecular MR imaging of VEGFR2 on angiogenic vasculature
Bongjune Kim et al.
NANOSCALE RESEARCH LETTERS (2013)
Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy
Huile Gao et al.
BIOMATERIALS (2012)
Selection of DNA Aptamers against Glioblastoma Cells with High Affinity and Specificity
Dezhi Kang et al.
PLOS ONE (2012)
In Vitro Selection of DNA Aptamers to Glioblastoma Multiforme
Abdullah Tahir Bayrac et al.
ACS CHEMICAL NEUROSCIENCE (2011)
Velocity Effect on Aptamer-Based Circulating Tumor Cell Isolation in Microfluidic Devices
Yuan Wan et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2011)
Role of MicroRNA-26b in Glioma Development and Its Mediated Regulation on EphA2
Ning Wu et al.
PLOS ONE (2011)
Surface-Immobilized Aptamers for Cancer Cell Isolation and Microscopic Cytology
Yuan Wan et al.
CANCER RESEARCH (2010)
Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis
Yingmiao Liu et al.
BIOLOGICAL CHEMISTRY (2009)
Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma
Joost J. C. Verhoeff et al.
EUROPEAN JOURNAL OF CANCER (2009)
Anti-EGFR Therapy: Mechanism and Advances in Clinical Efficacy in Breast Cancer
John F. Flynn et al.
JOURNAL OF ONCOLOGY (2009)
Advances in SELEX and application of aptamers in the central nervous system
Yan Yang et al.
BIOMOLECULAR ENGINEERING (2007)
Expression of EphA2 in human astrocytic tumors: Correlation with pathologic grade, proliferation and apoptosis
Xia Li et al.
TUMOR BIOLOGY (2007)
A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma
Fenghua Liu et al.
CANCER RESEARCH (2006)
EphA2 as a novel molecular marker and target in glioblastoma multiforme
J Wykosky et al.
MOLECULAR CANCER RESEARCH (2005)
Epidermal growth factor receptor inhibition strategies in oncology
PM Harari
ENDOCRINE-RELATED CANCER (2004)
A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment
DA Daniels et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tenascin-C aptamers are generated using tumor cells and purified protein
BJ Hicke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
